Trial intelligence / Profile preview

HP011-101 and HP828-101 for Pressure Ulcers

NCT01273428Phase 2Withdrawn

Sponsor
Healthpoint Biotherapeutics
Primary completion
Jun 2011
Modality
Recombinant Proteins and Enzymes, Small Molecules
01

Overview

A Phase 2 trial of balsam peru + castor oil + trypsin in pressure ulcer, sponsored by Healthpoint Biotherapeutics. Status: withdrawn.

02

Drugs

balsam peru + castor oil + trypsin
03

Conditions

pressure ulcer

Beyond the preview

Go deeper on NCT01273428.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01273428.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call